8-K: Oscar Health Holds Annual Meeting, Elects Directors

Sentiment:

Annual Meeting Results


Oscar Health, Inc. announced the results of its 2026 Annual Meeting of Stockholders, confirming the election of eight director nominees and the approval of executive compensation and auditor ratification.

Summary

  • Oscar Health, Inc. held its 2026 Annual Meeting of Stockholders on June 4, 2026.
  • The meeting confirmed the election of eight director nominees to serve until the 2027 Annual Meeting.
  • Stockholders also approved the advisory vote on named executive officer compensation.
  • The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026 was ratified.
  • A quorum was established with 820,307,497 votes of Common Stock represented.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it confirms routine corporate governance matters with strong shareholder support, indicating stability.

Positives

  • All eight director nominees were elected with substantial support.
  • The advisory vote to approve named executive officer compensation passed with a significant majority.
  • The appointment of PricewaterhouseCoopers LLP as the independent auditor was ratified with overwhelming approval.
  • A quorum was met, indicating strong shareholder participation or representation.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on the outcomes of the annual meeting.

Industry Context

StockSavvy.ai notes that the smooth execution of annual meetings and routine approvals like director elections and auditor ratification are standard corporate governance practices. The high vote counts suggest shareholder confidence in the current board and management's oversight.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director ElectionElection of eight director nominees to serve until the 2027 Annual Meeting.June 4, 2026Maintains continuity in board leadership and oversight.
Executive Compensation ApprovalAdvisory vote to approve named executive officer compensation.June 4, 2026Indicates shareholder support for the company's executive compensation policies.
Auditor RatificationRatification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.June 4, 2026Confirms the company's choice of auditor and supports financial transparency.

Stakeholder Impact

  • Shareholders: Confirmation of board composition and executive compensation policies provides clarity and stability.
  • Employees: Continued auditor relationship supports financial integrity, indirectly benefiting employees.
  • Creditors: Ratification of auditor and board elections reinforces corporate stability, which is positive for creditors.

Next Steps

  • The elected directors will serve until the 2027 Annual Meeting.
  • PricewaterhouseCoopers LLP will continue as the independent registered public accounting firm for 2026.

Key Dates

DateDescription
2026-04-10Record Date for determining stockholders entitled to vote at the Annual Meeting.
2026-06-04Date of the 2026 Annual Meeting of Stockholders.
2026-06-09Date of the signature on the Form 8-K filing.

Keywords

Oscar Health, Annual Meeting, Stockholders, Directors, Executive Compensation, Auditor Ratification, Corporate Governance, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.